SCHEMBL13624141

SCHEMBL13624141

CC(NC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1)c1cccc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 7/20 0.52
METAP2 P50579 5/20 0.46
KDM4E B2RXH2 3/20 0.46
TP53 P04637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TRPV1 Q8NER1 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
FKBP1A P62942 1/20 0.44
HIF1A Q16665 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376161 0.93 TRPV1 (0.45) METAP1METAP2KDM4ETP53NPC1
Trifluoroacetic Acid SCHEMBL4371839 0.88 METAP1 (0.43) METAP1METAP2KDM4ETP53NPC1
SCHEMBL13624140 0.87 METAP1 (0.56) METAP1METAP2KDM4ETP53NPC1
SCHEMBL13624132 0.80 METAP1 (0.64) METAP1METAP2KDM4ETP53NPC1
SCHEMBL4365319 0.79 METAP1 (0.48) METAP1METAP2KDM4ETP53NPC1
SCHEMBL4367957 0.79 METAP1 (0.48) METAP1METAP2KDM4ETP53NPC1
SCHEMBL4369718 0.79 METAP1 (0.63) METAP1METAP2KDM4ETP53NPC1
SCHEMBL4368578 0.77 METAP1 (0.58) METAP1METAP2KDM4ETP53NPC1
SCHEMBL4371844 0.77 TRPV1 (0.40) TRPV1HDAC6IDH1
SCHEMBL11208586 0.76 METAP1 (0.63) METAP1METAP2KDM4ETP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622592-B2 Carbonylamino-benzimidazole derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-11-24 US disclosed